PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2018
Total Assets: $71.4K
Liabilities Breakdown FY2018
Total Liabilities: $6.8M
Asset Breakdown
Total Assets: $71.4K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $0 | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.3K | 11.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $63.1K | 88.4% |
Liabilities Breakdown
Total Liabilities: $6.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 17.0% |
| Long-Term Debt | $4.7M | 68.9% |
| Other Liabilities | $966.6K | 14.2% |